Found: 32
Select item for more details and to access through your institution.
Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 6, p. 995, doi. 10.1002/pon.5889
- By:
- Publication type:
- Article
Palliative care services in neuro-oncology: Mind the gap.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 5, p. 513, doi. 10.1093/nop/npae072
- By:
- Publication type:
- Article
Advance care planning in glioblastoma patients: development of a disease-specific ACP program.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Depression and anxiety in glioma patients.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 4, p. 335, doi. 10.1093/nop/npad019
- By:
- Publication type:
- Article
Valproic acid in glioma: Will the anticancer issue ever be solved?
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 1, p. 1, doi. 10.1093/nop/npac091
- By:
- Publication type:
- Article
Advance care planning (ACP) in glioblastoma patients: Evaluation of a disease-specific ACP program and impact on outcomes.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 6, p. 496, doi. 10.1093/nop/npac050
- By:
- Publication type:
- Article
Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 2, p. 105, doi. 10.1093/nop/npab059
- By:
- Publication type:
- Article
Identification of characteristics that determine behavioral and personality changes in adult glioma patients.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 550, doi. 10.1093/nop/npab041
- By:
- Publication type:
- Article
Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 501, doi. 10.1093/nop/npab030
- By:
- Publication type:
- Article
Determining medical decision-making capacity in brain tumor patients: why and how?
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 6, p. 599, doi. 10.1093/nop/npaa040
- By:
- Publication type:
- Article
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study.
- Published in:
- BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01343-4
- By:
- Publication type:
- Article
Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 2, doi. 10.1186/s12883-014-0157-4
- By:
- Publication type:
- Article
Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging.
- Published in:
- NMR in Biomedicine, 2024, v. 37, n. 9, p. 1, doi. 10.1002/nbm.5166
- By:
- Publication type:
- Article
Advance Care Planning in Glioblastoma Patients.
- Published in:
- Cancers, 2016, v. 8, n. 11, p. 102, doi. 10.3390/cancers8110102
- By:
- Publication type:
- Article
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 515, doi. 10.1093/neuonc/noz200
- By:
- Publication type:
- Article
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 1, p. 12, doi. 10.1093/neuonc/now190
- By:
- Publication type:
- Article
Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 7, p. 924, doi. 10.1093/neuonc/nov032
- By:
- Publication type:
- Article
First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy.
- Published in:
- Epilepsia (Series 4), 2023, v. 64, n. 1, p. 162, doi. 10.1111/epi.17464
- By:
- Publication type:
- Article
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
- Published in:
- Epilepsia (Series 4), 2021, v. 62, n. 5, p. 1119, doi. 10.1111/epi.16880
- By:
- Publication type:
- Article
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad133
- By:
- Publication type:
- Article
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 154, n. 1, p. 73, doi. 10.1007/s11060-021-03800-z
- By:
- Publication type:
- Article
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 153, n. 1, p. 89, doi. 10.1007/s11060-021-03747-1
- By:
- Publication type:
- Article
Prediagnostic symptoms and signs of adult glioma: the patients' view.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 2, p. 293, doi. 10.1007/s11060-019-03373-y
- By:
- Publication type:
- Article
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 7, doi. 10.1093/neuonc/noad154
- By:
- Publication type:
- Article
Reply to the letter regarding "Palliative care and end-of-life care in adults with malignant brain tumors".
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 7, p. 1377, doi. 10.1093/neuonc/noad069
- By:
- Publication type:
- Article
IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 4, p. 701, doi. 10.1093/neuonc/noac197
- By:
- Publication type:
- Article
Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 447, doi. 10.1093/neuonc/noac216
- By:
- Publication type:
- Article
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Letter regarding "SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors".
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 499, doi. 10.1093/neuonc/noab283
- By:
- Publication type:
- Article
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 326, doi. 10.1093/neuonc/noab258
- By:
- Publication type:
- Article